Cerus (CERS) Net Income Growth (1y) (2011 - 2026)
Cerus (CERS) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 125.69% |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | 78.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.65% |
| Dec 31, 2025 | -4.10% |
| Sep 30, 2025 | 99.32% |
| Jun 30, 2025 | 1.04% |
| Mar 31, 2025 | 20.35% |
| Dec 31, 2024 | -51.48% |
| Sep 30, 2024 | 59.73% |
| Jun 30, 2024 | 56.68% |
| Mar 31, 2024 | 38.05% |
| Dec 31, 2023 | 90.37% |
| Sep 30, 2023 | 14.49% |
| Jun 30, 2023 | -58.80% |
| Mar 31, 2023 | -27.33% |
| Dec 31, 2022 | -664.08% |
| Sep 30, 2022 | 31.49% |
| Jun 30, 2022 | 45.35% |
| Mar 31, 2022 | 29.63% |
| Dec 31, 2021 | 178.22% |
| Sep 30, 2021 | 12.04% |
| Jun 30, 2021 | -3.30% |